These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

412 related items for PubMed ID: 9815715

  • 1. Incidence and timing of p53 mutations during astrocytoma progression in patients with multiple biopsies.
    Watanabe K, Sato K, Biernat W, Tachibana O, von Ammon K, Ogata N, Yonekawa Y, Kleihues P, Ohgaki H.
    Clin Cancer Res; 1997 Apr; 3(4):523-30. PubMed ID: 9815715
    [Abstract] [Full Text] [Related]

  • 2. p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression.
    Fults D, Brockmeyer D, Tullous MW, Pedone CA, Cawthon RM.
    Cancer Res; 1992 Feb 01; 52(3):674-9. PubMed ID: 1346255
    [Abstract] [Full Text] [Related]

  • 3. High frequency of p53 protein accumulation without p53 gene mutation in human juvenile pilocytic, low grade and anaplastic astrocytomas.
    Lang FF, Miller DC, Pisharody S, Koslow M, Newcomb EW.
    Oncogene; 1994 Mar 01; 9(3):949-54. PubMed ID: 8108140
    [Abstract] [Full Text] [Related]

  • 4. Detection of a novel point mutation in the p53 gene in grade II astrocytomas by PCR-SSCP analysis with additional Klenow treatment.
    Chawengchao B, Petmitr S, Ponglikitmongkol M, Chanyavanich V, Sangruji T, Theerapuncharoen V, Hayashi K, Thangnipon W.
    Anticancer Res; 2001 Mar 01; 21(4A):2739-43. PubMed ID: 11724349
    [Abstract] [Full Text] [Related]

  • 5. Reappraisal of p53 mutations in human malignant astrocytic neoplasms by p53 functional assay: comparison with conventional structural analyses.
    Tada M, Iggo RD, Waridel F, Nozaki M, Matsumoto R, Sawamura Y, Shinohe Y, Ikeda J, Abe H.
    Mol Carcinog; 1997 Mar 01; 18(3):171-6. PubMed ID: 9115587
    [Abstract] [Full Text] [Related]

  • 6. [Mutations of p53 gene in 41 cases of human brain gliomas].
    Cui W, Kong X, Cao HL, Wang X, Gao JF, Wu RL, Wang XC.
    Ai Zheng; 2008 Jan 01; 27(1):8-11. PubMed ID: 18184456
    [Abstract] [Full Text] [Related]

  • 7. Prognostic impact of TP53 mutations and P53 protein overexpression in supratentorial WHO grade II astrocytomas and oligoastrocytomas.
    Peraud A, Kreth FW, Wiestler OD, Kleihues P, Reulen HJ.
    Clin Cancer Res; 2002 May 01; 8(5):1117-24. PubMed ID: 12006527
    [Abstract] [Full Text] [Related]

  • 8. Chromosome 10 and 17 deletions and p53 gene mutations in Thai patients with astrocytomas.
    Put-Ti-Noi S, Petmitr S, Chanyavanich V, Sangruji T, Theerapuncharoen V, Hayashi K, Thangnipon W.
    Oncol Rep; 2004 Jan 01; 11(1):207-11. PubMed ID: 14654927
    [Abstract] [Full Text] [Related]

  • 9. Prognostic impact of TP53 mutation status for adult patients with supratentorial World Health Organization Grade II astrocytoma or oligoastrocytoma: a long-term analysis.
    Ständer M, Peraud A, Leroch B, Kreth FW.
    Cancer; 2004 Sep 01; 101(5):1028-35. PubMed ID: 15329912
    [Abstract] [Full Text] [Related]

  • 10. Possible association of p53 codon 72 polymorphism with susceptibility to adult and pediatric high-grade astrocytomas.
    Parhar P, Ezer R, Shao Y, Allen JC, Miller DC, Newcomb EW.
    Brain Res Mol Brain Res; 2005 Jun 13; 137(1-2):98-103. PubMed ID: 15950766
    [Abstract] [Full Text] [Related]

  • 11. Role of gemistocytes in astrocytoma progression.
    Watanabe K, Tachibana O, Yonekawa Y, Kleihues P, Ohgaki H.
    Lab Invest; 1997 Feb 13; 76(2):277-84. PubMed ID: 9042164
    [Abstract] [Full Text] [Related]

  • 12. Ethnicity delineates different genetic pathways in malignant glioma.
    Chen P, Aldape K, Wiencke JK, Kelsey KT, Miike R, Davis RL, Liu J, Kesler-Diaz A, Takahashi M, Wrensch M.
    Cancer Res; 2001 May 15; 61(10):3949-54. PubMed ID: 11358811
    [Abstract] [Full Text] [Related]

  • 13. Molecular genetic analysis of p53 intratumoral heterogeneity in human astrocytic brain tumors.
    Ren ZP, Olofsson T, Qu M, Hesselager G, Soussi T, Kalimo H, Smits A, Nistér M.
    J Neuropathol Exp Neurol; 2007 Oct 15; 66(10):944-54. PubMed ID: 17917588
    [Abstract] [Full Text] [Related]

  • 14. Absence of p53 autoantibodies in sera from glioma patients.
    Rainov NG, Dobberstein KU, Fittkau M, Bahn H, Holzhausen HJ, Gantchev L, Burkert W.
    Clin Cancer Res; 1995 Jul 15; 1(7):775-81. PubMed ID: 9816045
    [Abstract] [Full Text] [Related]

  • 15. Clonal expansion of p53 mutant cells is associated with brain tumour progression.
    Sidransky D, Mikkelsen T, Schwechheimer K, Rosenblum ML, Cavanee W, Vogelstein B.
    Nature; 1992 Feb 27; 355(6363):846-7. PubMed ID: 1311419
    [Abstract] [Full Text] [Related]

  • 16. p53 abnormality and tumor invasion in patients with malignant astrocytoma.
    Momota H, Narita Y, Matsushita Y, Miyakita Y, Shibui S.
    Brain Tumor Pathol; 2010 Oct 27; 27(2):95-101. PubMed ID: 21046311
    [Abstract] [Full Text] [Related]

  • 17. Mutations in the p53 gene in human astrocytomas: detection by single-strand conformation polymorphism analysis and direct DNA sequencing.
    Hunter SB, Bandea C, Swan D, Abbott K, Varma VA.
    Mod Pathol; 1993 Jul 27; 6(4):442-5. PubMed ID: 8415589
    [Abstract] [Full Text] [Related]

  • 18. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus.
    Bian YS, Osterheld MC, Bosman FT, Benhattar J, Fontolliet C.
    Mod Pathol; 2001 May 27; 14(5):397-403. PubMed ID: 11353048
    [Abstract] [Full Text] [Related]

  • 19. p53 mutation, EGFR gene amplification and loss of heterozygosity on chromosome 10, 17 p in human gliomas.
    Jin W, Xu X, Yang T, Hua Z.
    Chin Med J (Engl); 2000 Jul 27; 113(7):662-6. PubMed ID: 11776043
    [Abstract] [Full Text] [Related]

  • 20. Detection of p53 gene mutations in human brain tumors by single-strand conformation polymorphism analysis of polymerase chain reaction products.
    Mashiyama S, Murakami Y, Yoshimoto T, Sekiya T, Hayashi K.
    Oncogene; 1991 Aug 27; 6(8):1313-8. PubMed ID: 1886708
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.